Clinical Trials Browser

Phase 2 × Platinum Compounds × Gastrointestinal × Clear all

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT02845986 2020-02-05

CLASS-04

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms